Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of patiromer on pharmacokinetics of tacrolimus in renal transplant recipients
2020-002621-29Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Nov 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of patiromer in hyperkalemia (2 arms), sponsored by Oslo University Hospital. Primary endpoint: AUC tacrolimus without and with patiromer. Started Nov 2020; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on 2020-002621-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002621-29.